257 essays 1,087 funds measured independent · not paid by any fund or issuer we cover

Fund · iShares U.S. Consumer Staples ETF · measured from SEC filings

IYK holdings

IYK reports 55 holdings and behaves like 15.4 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.

Measured concentration

as of 2026-07-31
55 Positions reported
15.4 Effective holdings
3.6× Concentration multiple
66.35% Top ten weight

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 3 issuer countries.

What stands out

as of 2026-07-31

IYK's largest investment is Procter Gamble Co THE at 13.58% of net assets. Coca Cola Co and Philip Morris International follow; the three together are 35.95%. Ten companies are 66.35% of the fund; the other 45 share the rest. Among the 721 equity funds measured here, IYK behaves like 15.4 holdings against a median of 42.4 — 2.8 times more concentrated than the median. Across 27 quarterly filings IYK has become more concentrated: it behaved like 20.8 at 2019-10-31 and 15.5 at 2026-04-30. Between the 2026-01-31 and 2026-04-30 filings 1 positions were added and 1 dropped; 3.9% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Every filing since 2019

27

Between 2019-10-31 and 2026-04-30, IYK went from behaving like 20.8 equally weighted positions to 15.5 — 26% fewer, while its top ten went from 55.81% to 67.14% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-04-30 56 15.5 67.14% 13.61%
2026-01-31 56 15 67.97% 14.28%
2025-10-31 56 15.3 67.11% 15.05%
2025-07-31 57 15.7 66.09% 14.6%
2025-04-30 58 15.4 66.63% 15.04%
2025-01-31 57 14.8 66.46% 16.86%
2024-10-31 56 15.4 65.31% 15.9%
2024-07-31 56 14.9 67.38% 16.11%
Earlier filings (19 more, back to 2019-10-31)
PeriodHoldingsEffectiveTop 10Largest
2024-04-30 57 14.4 66.37% 17.25%
2024-01-31 57 14.6 65.85% 17.06%
2023-10-31 56 14.6 66.05% 16.97%
2023-07-31 55 14.8 65.48% 16.29%
2023-04-30 54 14.7 65.61% 16.17%
2023-01-31 54 15.3 64.24% 15.5%
2022-10-31 54 15.5 64.13% 15.06%
2022-07-31 54 15.2 64.25% 15.3%
2022-04-30 55 14.6 64.39% 17.1%
2022-01-31 56 14.8 65.04% 16.91%
2021-10-31 57 14.9 64.81% 16.66%
2021-07-31 102 17.7 60.09% 15.81%
2021-04-30 101 17.8 58.62% 16.66%
2021-01-31 99 15.2 60.77% 19.46%
2020-10-31 98 19.2 59.4% 13.25%
2020-07-31 109 20.6 58.63% 13.27%
2020-04-30 108 20 59.08% 13.92%
2020-01-31 106 21.1 57.1% 13.06%
2019-10-31 109 20.8 55.81% 13.78%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Largest positions, as filed

as of 2026-04-30

The 15 largest of 55 positions in IYK's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: IYK.csv.gz.

#PositionWeightCumulative
1THE PROCTER & GAMBLE COMPANY13.61%13.6%
2THE COCA-COLA COMPANY12.15%25.8%
3Philip Morris International Inc.10.27%36.0%
4Pepsico, Inc.8.75%44.8%
5Altria Group, Inc.4.85%49.6%
6CVS HEALTH CORPORATION4.30%53.9%
7MCKESSON CORPORATION3.96%57.9%
8Mondelez International, Inc.3.55%61.4%
9COLGATE-PALMOLIVE COMPANY3.05%64.5%
10CORTEVA, INC.2.66%67.1%
11CENCORA, INC.2.61%69.7%
12MONSTER BEVERAGE CORPORATION2.60%72.3%
13THE KROGER CO.1.91%74.3%
14KEURIG DR PEPPER INC.1.84%76.1%
15SYSCO CORPORATION1.73%77.8%

By country of issuer

as of 2026-04-30

Share of IYK's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

CountryShare
United States 99.20%
Switzerland 0.80%

Returns the fund reported

2019-08 – 2026-04

Monthly total returns from Item B.5 of IYK's own filings, 81 months on record. Not computed here and not from a price feed.

3.8%Last twelve months filed
102%Whole series, compounded
12.8%Best month
-11.8%Worst month

Cross-checked against a series computed separately from prices: median difference 0.05 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: IYK.json · all funds.

Who borrows IYK's shares

2026-07-31

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $4m was out to 4 borrowers. The largest, BofA Securities, Inc., held 65.3% of it.

BorrowerOn loanShare of the loan
BofA Securities, Inc. $3m 65.3%
GOLDMAN SACHS INTERNATIONAL $1m 32.2%
BARCLAYS BANK PLC $67,592 1.6%
CITIGROUP GLOBAL MARKETS INC. $36,564 0.9%

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter IYK has filed, with each borrower: IYK.json · all funds.

Since the previous filing

2026-01-31 → 2026-04-30

56 positions became 56: 1 added (0.0% of the fund at the later date), 1 dropped (0.0% at the earlier date). Half the sum of all weight changes, a turnover proxy: 3.9%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of IYK compared this way, as a feed: changes.xml · all funds: filings received.

Largest increases2026-01-312026-04-30Largest decreases2026-01-312026-04-30
Altria Group, Inc.4.32%4.85% Philip Morris International Inc.11.33%10.27%
CVS HEALTH CORPORATION3.86%4.30% THE PROCTER & GAMBLE COMPANY14.28%13.61%
THE COCA-COLA COMPANY11.72%12.15% CENCORA, INC.2.97%2.61%
CASEY'S GENERAL STORES, INC.1.05%1.47% MCKESSON CORPORATION4.29%3.96%
CORTEVA, INC.2.34%2.66% GENERAL MILLS, INC.1.16%0.91%
ARCHER-DANIELS-MIDLAND COMPANY.1.51%1.73% COLGATE-PALMOLIVE COMPANY3.27%3.05%

New: XAP CONS STAPLES JUN26 (0.01%). Gone: XAP CONS STAPLES MAR26 (0.01%).

Asset categories and pricing

as of 2026-07-31

99.57% equity, 0.43% short-term investment as filed; 100.0% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Derivative exposure and counterparties

as of 2026-04-30

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $1.39B. Notional of an interest-rate or currency swap is not equity exposure.

99.62%Stocks held directly
0%Swap notional (0)
0.35%Futures notional (1)
100%Sum, % of net assets

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Neighbours by effective holdings, equity funds

10

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of IYK (15.4). Same filings, same arithmetic. Position in this list says nothing about which fund is better.

FundReportsBehaves likeTop tenAs of
GREK Global X MSCI Greece ETF 33 15 70.7% 2026-07-31
VGT Vanguard Information Technology Index Fund 321 15.1 59.38% 2026-05-31
QQH HCM Defender 100 Index ETF 100 15.1 62.71% 2026-06-30
SLVP iShares MSCI Global Silver and Metals Miners ETF 47 15.2 69.95% 2026-05-31
EWA iShares MSCI Australia ETF 50 15.3 65.27% 2026-05-31
IYW iShares U.S. Technology ETF 150 16 65.25% 2026-07-31
DTCR Global X Data Center & Digital Infrastructure ETF 25 16.1 66.32% 2026-05-31
FAS Direxion Daily Financial Bull 3X Shares 88 16.2 * 59.29% 2026-07-31
XLK State Street(R) Technology Select Sector SPDR(R) ETF 77 16.3 64.47% 2026-06-30
XLV State Street(R) Health Care Select Sector SPDR(R) ETF 64 16.3 61.59% 2026-06-30

Essays that examine IYK

0

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.